vs

Side-by-side financial comparison of CABOT CORP (CBT) and Western Midstream Partners, LP (WES). Click either name above to swap in a different company.

Western Midstream Partners, LP is the larger business by last-quarter revenue ($1.0B vs $849.0M, roughly 1.2× CABOT CORP). Western Midstream Partners, LP runs the higher net margin — 18.5% vs 8.6%, a 9.9% gap on every dollar of revenue. On growth, Western Midstream Partners, LP posted the faster year-over-year revenue change (11.0% vs -11.1%). Western Midstream Partners, LP produced more free cash flow last quarter ($335.4M vs $57.0M). Over the past eight quarters, Western Midstream Partners, LP's revenue compounded faster (7.8% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Sunoco LP is an American vehicle gasoline master limited partnership company organized under Delaware state law and headquartered in Dallas, Texas. Dating back to 1886, the company has transformed from a vertically integrated energy company to a distributor of fuels and operator of energy infrastructure. It was previously engaged in oil, natural gas exploration and production, refining, chemical manufacturing, and retail fuel sales, but divested these businesses.

CBT vs WES — Head-to-Head

Bigger by revenue
WES
WES
1.2× larger
WES
$1.0B
$849.0M
CBT
Growing faster (revenue YoY)
WES
WES
+22.1% gap
WES
11.0%
-11.1%
CBT
Higher net margin
WES
WES
9.9% more per $
WES
18.5%
8.6%
CBT
More free cash flow
WES
WES
$278.4M more FCF
WES
$335.4M
$57.0M
CBT
Faster 2-yr revenue CAGR
WES
WES
Annualised
WES
7.8%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBT
CBT
WES
WES
Revenue
$849.0M
$1.0B
Net Profit
$73.0M
$190.7M
Gross Margin
24.9%
Operating Margin
15.2%
29.7%
Net Margin
8.6%
18.5%
Revenue YoY
-11.1%
11.0%
Net Profit YoY
-21.5%
-42.8%
EPS (diluted)
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
WES
WES
Q4 25
$849.0M
$1.0B
Q3 25
$899.0M
$952.3M
Q2 25
$923.0M
$942.1M
Q1 25
$936.0M
$916.9M
Q4 24
$955.0M
$928.4M
Q3 24
$1.0B
$883.1M
Q2 24
$1.0B
$905.4M
Q1 24
$1.0B
$887.3M
Net Profit
CBT
CBT
WES
WES
Q4 25
$73.0M
$190.7M
Q3 25
$43.0M
$339.6M
Q2 25
$101.0M
$341.7M
Q1 25
$94.0M
$309.0M
Q4 24
$93.0M
$333.6M
Q3 24
$137.0M
$288.5M
Q2 24
$109.0M
$378.6M
Q1 24
$84.0M
$572.8M
Gross Margin
CBT
CBT
WES
WES
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Q1 24
24.1%
Operating Margin
CBT
CBT
WES
WES
Q4 25
15.2%
29.7%
Q3 25
15.2%
46.4%
Q2 25
18.1%
47.2%
Q1 25
17.3%
44.7%
Q4 24
16.2%
45.9%
Q3 24
15.0%
44.8%
Q2 24
16.9%
51.9%
Q1 24
15.3%
76.6%
Net Margin
CBT
CBT
WES
WES
Q4 25
8.6%
18.5%
Q3 25
4.8%
35.7%
Q2 25
10.9%
36.3%
Q1 25
10.0%
33.7%
Q4 24
9.7%
35.9%
Q3 24
13.7%
32.7%
Q2 24
10.7%
41.8%
Q1 24
8.2%
64.6%
EPS (diluted)
CBT
CBT
WES
WES
Q4 25
$1.37
Q3 25
$0.80
Q2 25
$1.86
Q1 25
$1.69
Q4 24
$1.67
Q3 24
$2.41
Q2 24
$1.94
Q1 24
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
WES
WES
Cash + ST InvestmentsLiquidity on hand
$230.0M
$819.5M
Total DebtLower is stronger
$8.2B
Stockholders' EquityBook value
$1.6B
Total Assets
$3.8B
$15.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
WES
WES
Q4 25
$230.0M
$819.5M
Q3 25
$258.0M
$177.3M
Q2 25
$239.0M
$129.7M
Q1 25
$213.0M
$448.4M
Q4 24
$183.0M
$1.1B
Q3 24
$223.0M
$1.1B
Q2 24
$197.0M
$344.1M
Q1 24
$206.0M
$295.2M
Total Debt
CBT
CBT
WES
WES
Q4 25
$8.2B
Q3 25
$1.1B
$6.9B
Q2 25
$6.9B
Q1 25
$6.9B
Q4 24
$6.9B
Q3 24
$1.1B
$6.9B
Q2 24
$7.1B
Q1 24
$7.3B
Stockholders' Equity
CBT
CBT
WES
WES
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.5B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.4B
Q2 24
$1.3B
Q1 24
$1.4B
Total Assets
CBT
CBT
WES
WES
Q4 25
$3.8B
$15.0B
Q3 25
$3.8B
$12.1B
Q2 25
$3.8B
$12.2B
Q1 25
$3.8B
$12.5B
Q4 24
$3.6B
$13.1B
Q3 24
$3.7B
$13.0B
Q2 24
$3.6B
$12.2B
Q1 24
$3.6B
$12.3B
Debt / Equity
CBT
CBT
WES
WES
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
WES
WES
Operating Cash FlowLast quarter
$126.0M
$557.6M
Free Cash FlowOCF − Capex
$57.0M
$335.4M
FCF MarginFCF / Revenue
6.7%
32.6%
Capex IntensityCapex / Revenue
8.1%
21.6%
Cash ConversionOCF / Net Profit
1.73×
2.92×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$1.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
WES
WES
Q4 25
$126.0M
$557.6M
Q3 25
$219.0M
$570.2M
Q2 25
$249.0M
$564.0M
Q1 25
$73.0M
$530.8M
Q4 24
$124.0M
$554.4M
Q3 24
$204.0M
$551.3M
Q2 24
$207.0M
$631.4M
Q1 24
$176.0M
$399.7M
Free Cash Flow
CBT
CBT
WES
WES
Q4 25
$57.0M
$335.4M
Q3 25
$155.0M
$385.5M
Q2 25
$188.0M
$385.4M
Q1 25
$1.0M
$388.4M
Q4 24
$47.0M
$315.7M
Q3 24
$112.0M
$361.9M
Q2 24
$155.0M
$419.6M
Q1 24
$133.0M
$205.9M
FCF Margin
CBT
CBT
WES
WES
Q4 25
6.7%
32.6%
Q3 25
17.2%
40.5%
Q2 25
20.4%
40.9%
Q1 25
0.1%
42.4%
Q4 24
4.9%
34.0%
Q3 24
11.2%
41.0%
Q2 24
15.3%
46.3%
Q1 24
13.1%
23.2%
Capex Intensity
CBT
CBT
WES
WES
Q4 25
8.1%
21.6%
Q3 25
7.1%
19.4%
Q2 25
6.6%
19.0%
Q1 25
7.7%
15.5%
Q4 24
8.1%
25.7%
Q3 24
9.2%
21.5%
Q2 24
5.1%
23.4%
Q1 24
4.2%
21.8%
Cash Conversion
CBT
CBT
WES
WES
Q4 25
1.73×
2.92×
Q3 25
5.09×
1.68×
Q2 25
2.47×
1.65×
Q1 25
0.78×
1.72×
Q4 24
1.33×
1.66×
Q3 24
1.49×
1.91×
Q2 24
1.90×
1.67×
Q1 24
2.10×
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

WES
WES

Segment breakdown not available.

Related Comparisons